Literature DB >> 24030251

Advanced glycated end-products affect HIF-transcriptional activity in renal cells.

Tzvetanka Bondeva1, Juliane Heinzig, Carola Ruhe, Gunter Wolf.   

Abstract

Advanced glycated end-products (AGEs) are ligands of the receptor for AGEs and increase in diabetic disease. MAPK organizer 1 (Morg1) via its binding partner prolyl-hydroxylase domain (PHD)-3 presumably plays a role in the regulation of hypoxia-inducible factor (HIF)-1α and HIF-2α transcriptional activation. The purpose of this study was to analyze the influence of AGEs on Morg1 expression and its correlation to PHD3 activity and HIF-transcriptional activity in various renal cell types. The addition of glycated BSA (AGE-BSA) significantly up-regulated Morg1 mRNA levels in murine mesangial cells and down-regulated it in murine proximal tubular cells and differentiated podocytes. These effects were reversible when the cells were preincubated with a receptor for α-AGE antibody. AGE-BSA treatment induced a relocalization of the Morg1 cellular distribution compared with nonglycated control-BSA. Analysis of PHD3 activity demonstrated an elevated PHD3 enzymatic activity in murine mesangial cells but an inhibition in murine proximal tubular cells and podocytes after the addition of AGE-BSA. HIF-transcriptional activity was also affected by AGE-BSA treatment. Reporter gene assays and EMSAs showed that AGEs regulate HIF- transcriptional activity under nonhypoxic conditions in a cell type-specific manner. In proximal tubular cells, AGE-BSA stimulation elevated mainly HIF-1α transcriptional activity and to a lesser extent HIF-2α. We also detected an increased expression of the HIF-1α and the HIF-2α proteins in kidneys from Morg1 heterozygous (HZ) placebo mice compared with the Morg1 wild-type (WT) placebo-treated mice, and the HIF-1α protein expression in the Morg1 HZ streptozotocin-treated mice was significantly higher than the WT streptozotocin-treated mice. Analysis of isolated mesangial cells from Morg1 HZ (±) and WT mice showed an inhibited PHD3 activity and an increased HIF-transcriptional activity in cells with only one Morg1 allele. These findings are important for a better understanding of the molecular mechanisms of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030251      PMCID: PMC5427833          DOI: 10.1210/me.2013-1036

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  56 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Coordinating ERK/MAPK signalling through scaffolds and inhibitors.

Authors:  Walter Kolch
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

3.  Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.

Authors:  Wanja M Bernhardt; Valentina Câmpean; Sarah Kany; Jan-Steffen Jürgensen; Alexander Weidemann; Christina Warnecke; Michael Arend; Stephen Klaus; Volkmar Günzler; Kerstin Amann; Carsten Willam; Michael S Wiesener; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2006-06-08       Impact factor: 10.121

4.  Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury.

Authors:  Yared Tekabe; Joane Luma; Qing Li; Ann Marie Schmidt; Ravichandran Ramasamy; Lynne L Johnson
Journal:  JACC Cardiovasc Imaging       Date:  2012-01

5.  Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

Authors:  Nozomu Tanji; Glen S Markowitz; Caifeng Fu; Thomas Kislinger; Akihiko Taguchi; Monika Pischetsrieder; David Stern; Ann Marie Schmidt; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

6.  The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.

Authors:  Francesco Cipollone; Annalisa Iezzi; Maria Fazia; Mirco Zucchelli; Barbara Pini; Chiara Cuccurullo; Domenico De Cesare; Giovanni De Blasis; Raffaella Muraro; Roberto Bei; Francesco Chiarelli; Ann Marie Schmidt; Franco Cuccurullo; Andrea Mezzetti
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

7.  Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites.

Authors:  Tzvetanka Bondeva; Thierry Roger; Gunter Wolf
Journal:  Am J Nephrol       Date:  2007-05-08       Impact factor: 3.754

8.  Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.

Authors:  Christiane Rüster; Tzvetanka Bondeva; Sybille Franke; Nobushige Tanaka; Hiroshi Yamamoto; Gunter Wolf
Journal:  Am J Nephrol       Date:  2009-01-08       Impact factor: 3.754

Review 9.  Growth factors and the development of diabetic nephropathy.

Authors:  Gunter Wolf
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

10.  Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis.

Authors:  T P Haverty; C J Kelly; W H Hines; P S Amenta; M Watanabe; R A Harper; N A Kefalides; E G Neilson
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

View more
  7 in total

Review 1.  Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.

Authors:  Milton Packer
Journal:  J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 10.121

Review 2.  Hypoxia driven glycation: Mechanisms and therapeutic opportunities.

Authors:  Mohammad Imran Khan; Suvasmita Rath; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Semin Cancer Biol       Date:  2017-05-22       Impact factor: 15.707

3.  Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.

Authors:  Stefano Menini; Carla Iacobini; Carlo Ricci; Claudia Blasetti Fantauzzi; Giuseppe Pugliese
Journal:  Diabetologia       Date:  2014-12-04       Impact factor: 10.122

4.  Glucose promotes secretion-dependent renal cyst growth.

Authors:  Andre Kraus; Gunnar Schley; Karl Kunzelmann; Rainer Schreiber; Dorien J M Peters; Ruth Stadler; Kai-Uwe Eckardt; Bjoern Buchholz
Journal:  J Mol Med (Berl)       Date:  2015-09-03       Impact factor: 4.599

5.  Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.

Authors:  Ying Shao; Chuan Lv; Qin Yuan; Qiuyue Wang
Journal:  J Diabetes Res       Date:  2016-03-16       Impact factor: 4.011

6.  MORG1-A Negative Modulator of Renal Lipid Metabolism in Murine Diabetes.

Authors:  Eric Jankowski; Sophie Wulf; Nadja Ziller; Gunter Wolf; Ivonne Loeffler
Journal:  Biomedicines       Date:  2021-12-23

7.  Cloning of the Human MORG1 Promoter: Differential Regulation by Hypoxia and Prolyl-Hydroxylase Inhibitors.

Authors:  Tzvetanka Bondeva; Gunter Wolf
Journal:  Genes (Basel)       Date:  2022-02-25       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.